Hepatocyte-Derived Exosomes Reduce Hepatic Ischemia-Reperfusion (IR) Injury by Inhibiting Complement Activation
Frontiers in Bioscience-Landmark · 2025
DOI: 10.31083/fbl46946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Zhi Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, The First Affiliated Hospital of Guilin Medical University, 541001 Guilin, G…. Hauptthemen laut MEDLINE: Exosomes, Reperfusion Injury, Hepatocytes, Liver. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangxi, Special Fund of the Central Government Guiding Local Scientific and Technological Development by Guangxi Science and Technology Department, Lijiang Scholar Award in Guilin.
Abstract (Originalsprache)
Background
Exosomes are specialized secreted vesicles for intercellular communication and signaling pathways as specialized secreted vesicles. Multiple studies have suggested the potential roles of hepatocyte-derived exosomes as biomarkers of liver injury and facilitators of hepatocyte proliferation and liver regeneration.
Methods
By utilizing murine models of hepatic ischemia-reperfusion injury (IRI), we examined the impact of hepatocyte-derived exosomes on mitigating hepatic IRI.
Results
Our experiments have demonstrated that significantly lower levels of alanine transaminase, aspartate transaminase, and lactate dehydrogenase in mice treated with hepatocyte-derived exosomes compared with mice treated with phosphate-buffered saline (PBS). Furthermore, hepatocyte-derived exosomes inhibited hepatocyte apoptosis, reduced levels of inflammatory cytokines, and suppressed the entry of inflammatory cells into the liver following hepatic IRI. Complement 3d (C3d) expression showed a notable decrease in exosome-treated mice compared with PBS-treated mice, suggesting that hepatocyte-derived exosomes effectively inhibited complement activation during hepatic IRI. Blocking the fusion of exosomes with cells using Annexin V weakened the protective effects of the exosomes against hepatic IRI.
Conclusions
Our findings highlight the ability of hepatocyte-derived exosomes to mitigate hepatic IRI by inhibiting complement activation. These results reveal a novel role for exosomes in blocking complement activation, suggesting a potential new therapeutic avenue for preventing hepatic IRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, The First Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, China.
- Guangxi Health Commission Key Laboratory of Basic Research in Sphingolipid Metabolism Related Diseases, The First Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, China.
- China-USA Lipids in Health and Disease Research Center, Guilin Medical University, 541001 Guilin, Guangxi, China.
- Laboratory of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Guilin Medical University, 541001 Guilin, Guangxi, China.
Förderung
- Natural Science Foundation of Guangxi
- Special Fund of the Central Government Guiding Local Scientific and Technological Development by Guangxi Science and Technology Department
- Lijiang Scholar Award in Guilin
- Science and Technology Planned Project in Guilin
- Medical High Level Talents Training Plan in Guangxi
- Construction Fund of Guangxi Health Commission Key Laboratory of Basic Research in Sphingolipid Metabolism Related Diseases (the Affiliated Hospital of Guilin…
- Guangxi Medical and Health Key Discipline Construction Project
- Construction Fund of Guangxi Health Commission Key Laboratory of Basic Research in Sphingolipid Metabolism Related Diseases
Zitieren
APA
Yang, Z., Deng, B., Sun, T., Wang, Y., Dong, W., Jin, J., & Pan, Z. (2025). Hepatocyte-Derived Exosomes Reduce Hepatic Ischemia-Reperfusion (IR) Injury by Inhibiting Complement Activation. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl46946
Vancouver
Yang Z, Deng B, Sun T, Wang Y, Dong W, Jin J, et al. Hepatocyte-Derived Exosomes Reduce Hepatic Ischemia-Reperfusion (IR) Injury by Inhibiting Complement Activation. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl46946
BibTeX
@article{Yang2025,
author = {Yang, Zhi and Deng, Bin and Sun, Tian and Wang, Yongqin and Dong, Wei and Jin, Junfei and Pan, Zhixiong},
title = {Hepatocyte-Derived Exosomes Reduce Hepatic Ischemia-Reperfusion (IR) Injury by Inhibiting Complement Activation},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
doi = {10.31083/fbl46946}
}
EUVIMED